Protective effect of herbomineral formulation (Dolabi) on early diabetic nephropathy in streptozotocin-induced diabetic rats

Journal of Natural Medicines

Volumn 66, Issue 3, 2012, Pages 500-509

  Baig, Mirza A ^a   Gawali, Vikas B ^a   Patil, Rajesh R ^b   Naik, Suresh R ^b  

^a SINHGAD COLLEGE OF PHARMACY   (India)

^b Sinhgad Technical Education Society   (India)

Author keywords

Diabetic nephropathy; Herbomineral formulation; Hyperglycemia; Kidney antioxidants; Kidney histoarchitecture; Serum lipids

Indexed keywords

ALBUMIN; AMINOGUANIDINE; CATECHIN; CHOLESTEROL; CREATININE; DOLABI; GLUCOSE; GLUTATHIONE; GLYCOGEN; GLYCOSYLATED HEMOGLOBIN; GYMNEMIC ACID; HERBACEOUS AGENT; HERBOMINERAL FORMULATION; IRON; MALONALDEHYDE; MATRIX METALLOPROTEINASE; NITROGEN; OLEANOLIC ACID; QUERCETIN; RUTOSIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; ZINC OXIDE;

ACACIA; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAMBUSA; BAMBUSA ARUNDINACEA; CHICKEN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; EGG SHELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GYMNEMA SYLVESTRE; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY MASS; LIPID PEROXIDATION; MALE; MESANGIUM; NONHUMAN; RAT; RENAL PROTECTION; RUMEX; RUMEX VESICARIUS; STREPTOZOCIN DIABETES; SYZYGIUM CUMINI; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; URINE VOLUME;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPOGLYCEMIC AGENTS; KIDNEY; LIPID PEROXIDATION; MALONDIALDEHYDE; RATS; SUPEROXIDE DISMUTASE;

EID: 84863518327     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-011-0614-y     Document Type: Article

References (44)

1. Takako Y, Noriko Y, Eun JC, Tokako N, Shigeru O (2004) A study on the effect to diabetic nephropathy of Hachimi-jio-gan in rats. Nephron Exp Nephrol 97:e38-e48
2. Dronavalli S, Duka I, Bakris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4(8):444-452
3. Kikkawa R, Koya D, Haneda M (2003) Progression of diabetic nephropathy. Am J Kidney Dis 41(3-2):S19-S2
4. Wadood A, Wadood N, Shah SA (1989) Effects of Acacia arabica and Caralluma edulis on blood glucose levels of normal and alloxan diabetic rabbits. J Pak Med Assoc 39(8):208-212
5. Sagrawat H, Mann AS, Kharya MD (2006) Pharmacological potential of Eugenia jambolana: a review. Pharmacogn Mag 2(6):96-105
6. Gholap S, Kar A (2003) Effect of Inula racemosa root and Gymnema sylvestre leaf extract in the regulation of corticosteroid induced diabetes mellitus: involvement of thyroid hormones. Pharmazie 58:413-415
7. Robert A (2000) Zinc in relation to diabetes and oxidative disease. J Nutr 130(5):1509S-1511S
8. Sajeeth CI, Manna PK, Manavalan R, Jolly CI (2010) Quantitative estimation of gallic acid, rutin and quercetin in certain herbal plants by HPTLC method. Der Chemica Sinica 1(2):80-85
9. Nehete JY, Deshmukh VN, Shewale VV, Narkhede MR, Aurangabadkar VM (2009) Quantitation of oleanolic acid in Achyranthes aspera L. roots and leaves extracts by high-performance thin-layer chromatography. Int J Pharm Res Dev 2(7). ISSN 0974-9446
10. Trinder P (1969) Determination of blood glucose using an oxidase peroxidase system with a non-carcinogenic chromogen. Ann Clin Biochem 6:24-30
11. Anurag K, Anand S, Kanwaljit C (2009) Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol. J Agric Food Chem 57(14):6123-6128
12. Greg H, Terri J (2007) Methods in renal research: Rodent models of streptozotocin-induced diabetic nephropathy. Nephrol 12(3):261-266
13. Sassy-Prigent C, Heudes D, Jouquey S, Auberval D, Belair MF, Michel O et al (1995) Morphometric detection of incipientglomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition. Lab Invest 73:64-71
14. Godkar PB (1994) Clinical biochemistry: principles and practice, 3rd edn. Bhalani Publishing House, Bombay, pp 115-116
15. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95:351-355
16. Beutler E, Duron O, Kelly BM (1963) Improved method for determination of blood glutathione. J Lab Clin Med 61(5): 882-888
17. Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186(1):189-192
18. Yokozawa T, Nakagawa T, Wakaki K, Koizumi F (2001) Animal model of diabetic nephropathy. Exp Toxicol Pathol 53:359-363
19. Pitchai B, Vishal C, Vijay K, Akash J, Jayarami R, Manjeet S (2008) Experimental models for nephropathy. J Renin Angiotensin Aldosterone Syst 9:189-195
20. Gojo A, Utsunomiya K, Taniguchi K (2007) The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin- induced diabetic rats. Eur J Pharmacol 568:242-247
21. Singh J, Budhiraja S, Lal H, Arora BR (2006) Renoprotection by telmisartan versus benazepril in streptozotocin induced diabetic nephropathy. Iran J Pharmacol Ther 5:135-139
22. Larkins RG, Dunlop ME (1992) The link between hyperglycemia and diabetic nephropathy. Diabetologia 35:499-504
23. Murali B, Dhananjay N, Umrani G, Ramesh G (2003) Effect of chronic treatment with losartan on streptozotocin-induced renal dysfunction. Mol Cell Biochem 249:85-90
24. Cooper ME (1998) Pathogenesis, prevention and treatment of diabetic nephropathy. Lancet 352:213-219
25. Yebe-nishimura C (1998) Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev 50:21-33
26. Alhouli MJ, Thomson M, Al-Qattan K, Muslim Ali DJS (2010) Biochemical and histological changes in the kidney of streptozotocin- induced diabetic rats: effects of garlic and ginger compared to aspirin. FASEB J 24(Meeting abstract Supplement):659.1
27. Bjorn S, Stefan H, George J, Bo-Lennart J, Karin E, Britta I et al (2005) C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20:532-538
28. Derubertis FR, Craven PA (1994) Activation of protein kinase C in glomerular cells in diabetes: mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8
29. Saito T (1997) Abnormal lipid metabolism and renal disorders. Tohoku J Exp Med 181:321-333
30. Kramer-Guth A, Quaschning T, Greiber S, Wanner C (1996) Potential role of lipids in the progression of diabetic nephropathy. Clin Nephrol 46:262-265
31. Morgensen CE (1982) Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685-688
32. Bell DS (1991) Diabetic nephropathy: changing concepts of pathogenesis and treatment. Am J Med Sci 301:195-200
33. Williamson JR, Chang K, Frangos M, Hasan KS et al (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42(6):801-813
34. Ahmed FN, Naqvi FN, Shafiq F (2006) Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus. Ann N Y Acad Sci 1084:481-489
35. Evans J, Goldfine I, Maddux B, Grodsky G (2002) Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622
36. Aksoy N, Vural H, Sabuncu T, Aksoy S (2003) Effects of melatonin on oxidative antioxidative status of tissues in streptozotocin induced diabetic rats. Cell Biochem Funct 21(2):121-125
37. Otsyula M, King MS, Ketcham TG, Sanders RA, Watkins JB (2003) Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia. Int J Toxicol 22(6):423-427
38. Hazem H, Kataya H, Alaa Eldin A (2008) Red cabbage (Brassica oleracea) ameliorates diabetic nephropathy in rats. eCAM 5(3):281-287
39. Moore K, Roberts LJ (1998) Measurement of lipid peroxidation. Free Radic Res 28(6):659-671
40. Sundaram R, Mitra SK (2007) Antioxidant activity of ethyl acetate soluble fraction of Acacia arabica bark in rats. Ind J Pharmacol 39:33-38
41. Seyer-Hansen K (1976) Renal nephropathy in streptozotocin diabetic rats. Clin Sci Mol Med 51:551-555
42. Kang SS, Fears R, Noirot S, Mbanya JN, Yudkin J (1982) Changes in metabolism of rat kidney and liver caused by experimental diabetes by dietary sucrose. Diabetologia 22: 285-288
43. Yotsumoto T, Naitoh T, Tanaka S (1997) Effects of specific antagonist of angiotensin II receptors and captopril on diabetic nephropathy in mice. Jpn J Pharmacol 75:59-64
44. Thrailkill KM, Clay Bunn R, Fowlkes JL (2009) Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. Endocrine 35(1):1-10